STOCK TITAN

Apellis Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 8:15 a.m. ET. The presentation will include a live Q&A session and will be accessible via a webcast on the company’s website. A replay will be available for 30 days post-event, along with the presentation slides posted online at 8:00 a.m. ET on the same day. Apellis is focused on developing transformative therapies targeting the complement system for various debilitating diseases.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET.

The presentation and question and answer session will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 30 days following the event. A copy of the presentation slides will be also posted on the company’s website beginning on Monday, January 10, 2022, at 8:00 a.m. ET.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com 
617.599.8178


FAQ

When will Apellis Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Apellis Pharmaceuticals will present at the J.P. Morgan Healthcare Conference on January 10, 2022, at 8:15 a.m. ET.

Where can I watch the Apellis Pharmaceuticals presentation?

The presentation can be watched via a live webcast on the company’s 'Events and Presentations' page on their website.

Will there be a replay available for the Apellis Pharmaceuticals presentation?

Yes, a replay of the presentation will be available for 30 days following the event.

What time will the Apellis Pharmaceuticals presentation slides be available?

The presentation slides will be posted on the company's website at 8:00 a.m. ET on January 10, 2022.

What is Apellis Pharmaceuticals known for?

Apellis Pharmaceuticals specializes in developing therapies targeting the complement system for various diseases.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

4.11B
105.50M
13.98%
99.97%
18.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM